AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2022
Aug 18, 2022
35200_dirs_2022-08-18_d6ccae18-c47b-4835-b0a0-f5eae370f55b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2022-08-16
Reporting Person: Goswami Trishna (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-16 | Common Stock | P | 2631 | $1.90 | Acquired | 2631 | Direct |